These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 16750604

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Factors affecting the characteristics of rapidly disintegrating tablets in the mouth prepared by the crystalline transition of amorphous sucrose.
    Sugimoto M, Maejima T, Narisawa S, Matsubara K, Yoshino H.
    Int J Pharm; 2005 May 30; 296(1-2):64-72. PubMed ID: 15885456
    [Abstract] [Full Text] [Related]

  • 3. Effect of formulated ingredients on rapidly disintegrating oral tablets prepared by the crystalline transition method.
    Sugimoto M, Narisawa S, Matsubara K, Yoshino H, Nakano M, Handa T.
    Chem Pharm Bull (Tokyo); 2006 Feb 30; 54(2):175-80. PubMed ID: 16462059
    [Abstract] [Full Text] [Related]

  • 4. The preparation of rapidly disintegrating tablets in the mouth.
    Sugimoto M, Matsubara K, Koida Y, Kobayashi M.
    Pharm Dev Technol; 2001 Nov 30; 6(4):487-93. PubMed ID: 11775950
    [Abstract] [Full Text] [Related]

  • 5. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
    Dhumal RS, Shimpi SL, Paradkar AR.
    Acta Pharm; 2007 Sep 30; 57(3):287-300. PubMed ID: 17878109
    [Abstract] [Full Text] [Related]

  • 6. Amorphous Formulation and in Vitro Performance Testing of Instantly Disintegrating Buccal Tablets for the Emergency Delivery of Naloxone.
    Alqurshi A, Kumar Z, McDonald R, Strang J, Buanz A, Ahmed S, Allen E, Cameron P, Rickard JA, Sandhu V, Holt C, Stansfield R, Taylor D, Forbes B, Royall PG.
    Mol Pharm; 2016 May 02; 13(5):1688-98. PubMed ID: 26977787
    [Abstract] [Full Text] [Related]

  • 7. A new formulation for orally disintegrating tablets using a suspension spray-coating method.
    Okuda Y, Irisawa Y, Okimoto K, Osawa T, Yamashita S.
    Int J Pharm; 2009 Dec 01; 382(1-2):80-7. PubMed ID: 19686825
    [Abstract] [Full Text] [Related]

  • 8. The preparation of orally disintegrating tablets using a hydrophilic waxy binder.
    Abdelbary G, Prinderre P, Eouani C, Joachim J, Reynier JP, Piccerelle P.
    Int J Pharm; 2004 Jul 08; 278(2):423-33. PubMed ID: 15196646
    [Abstract] [Full Text] [Related]

  • 9. Preparation and evaluation of swelling induced-orally disintegrating tablets by microwave irradiation.
    Sano S, Iwao Y, Kimura S, Itai S.
    Int J Pharm; 2011 Sep 15; 416(1):252-9. PubMed ID: 21763765
    [Abstract] [Full Text] [Related]

  • 10. Impact of freezing procedure and annealing on the physico-chemical properties and the formation of mannitol hydrate in mannitol-sucrose-NaCl formulations.
    Hawe A, Friess W.
    Eur J Pharm Biopharm; 2006 Nov 15; 64(3):316-25. PubMed ID: 16875806
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of a novel sugar coating method for moisture protective tablets.
    Ando M, Ito R, Ozeki Y, Nakayama Y, Nabeshima T.
    Int J Pharm; 2007 May 24; 336(2):319-28. PubMed ID: 17258875
    [Abstract] [Full Text] [Related]

  • 12. Crystal growth formation in melt extrudates.
    Bruce C, Fegely KA, Rajabi-Siahboomi AR, McGinity JW.
    Int J Pharm; 2007 Aug 16; 341(1-2):162-72. PubMed ID: 17524578
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of rapidly disintegrating tablets manufactured by phase transition of sugar alcohols.
    Kuno Y, Kojima M, Ando S, Nakagami H.
    J Control Release; 2005 Jun 20; 105(1-2):16-22. PubMed ID: 15955365
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Use of calcined Mg-Al-hydrotalcite to enhance the stability of celecoxib in the amorphous form.
    Ambrogi V, Perioli L, Marmottini F, Rossi C.
    Eur J Pharm Biopharm; 2007 May 20; 66(2):253-9. PubMed ID: 17123798
    [Abstract] [Full Text] [Related]

  • 19. Water-solid interactions. III. Effect of glass transition temperature, Tg, and processing on tensile strength of compacts of lactose and lactose/polyvinyl pyrrolidone.
    Stubberud L, Arwidsson HG, Hjortsberg V, Graffner C.
    Pharm Dev Technol; 1996 Jul 20; 1(2):195-204. PubMed ID: 9552346
    [Abstract] [Full Text] [Related]

  • 20. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
    Zahedi P, Lee PI.
    Eur J Pharm Biopharm; 2007 Mar 20; 65(3):320-8. PubMed ID: 17182231
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.